BioNxt Solutions Inc. (CVE:BNXT) | WebDisclosure

Basculer en Français

9479	Companies
185504	Keywords
117879	Articles
99354	Press releases

Headlines Articles Press releases BioNxt Solutions Inc.

Home
Companies
BioNxt Solutions Inc.

BRIEF

published on 09/20/2025 at 01:35, 2 months 15 days ago

BioNxt Solutions Inc. fait appel à des conseillers en marchés financiers et à des professionnels des relations avec les investisseurs.

Relations Avec Les Investisseurs Marchés Des Capitaux Options Sur Actions Solutions BioNxt Terry Lynch
BRIEF

published on 09/20/2025 at 01:35, 2 months 15 days ago

BioNxt Solutions Inc. Engages Capital Markets Advisor and Investor Relations Professionals

Stock Options Investor Relations Capital Markets BioNxt Solutions Terry Lynch
PRESS RELEASE

published on 09/20/2025 at 01:30, 2 months 15 days ago

Terry Lynch Continues as Capital Markets Advisor and BioNxt Retains Investor Relations Professionals
BioNxt Solutions Inc. announces Terry Lynch as capital markets advisor and retention of two investor relations professionals, Rob Grace and Blaine Ruzcki, for promotional activities. Company focuses on bioscience innovations with drug delivery platforms

BioNxt Solutions Inc. Terry Lynch Investor Relations Professionals Bioscience Innovations Drug Delivery Platforms
BRIEF

published on 09/15/2025 at 09:10, 2 months 20 days ago

BioNxt Progresses with Semaglutide Oral Film Program

Patent Filing Prototype Development BioNxt Semaglutide ODF GLP-1 Market
BRIEF

published on 09/15/2025 at 09:10, 2 months 20 days ago

BioNxt progresse avec son programme de films oraux à base de sémaglutide

Dépôt De Brevet Développement De Prototypes BioNxt Semaglutide ODF Marché Du GLP-1
PRESS RELEASE

published on 09/15/2025 at 09:05, 2 months 20 days ago

BioNxt Advances Semaglutide Oral Dissolvable Film (ODF) Program with Successful Proof-of-Concept and Prototype Development
BioNxt achieves successful proof-of-concept trials for Semaglutide oral dissolvable film program, advancing to next development phase in GLP-1 market for diabetes and obesity therapies

Drug Delivery Semaglutide BioNxt GLP-1 Market Proof-of-concept
BRIEF

published on 09/13/2025 at 01:05, 2 months 22 days ago

BioNxt Settles Debt with Share and Cash Agreement

Debt Settlement Canadian Securities Exchange Regulatory Approvals BioNxt Solutions Share Agreement
BRIEF

published on 09/13/2025 at 01:05, 2 months 22 days ago

BioNxt règle sa dette grâce à un accord en actions et en espèces

Bourse Des Valeurs Canadiennes Approbations Réglementaires Règlement De La Dette Solutions BioNxt Accord De Partage
PRESS RELEASE

published on 09/13/2025 at 01:00, 2 months 22 days ago

BioNxt Announces Shares for Debt Settlement
BioNxt Solutions Inc. announces a debt settlement agreement with a creditor, issuing common shares and making a cash payment. Company focuses on bioscience innovations and drug delivery technologies

Innovation Debt Settlement BioScience Drug Delivery BioNxt
BRIEF

published on 09/05/2025 at 09:10, 3 months ago

BioNxt Solutions Debuts on OTCQB Market

Financial Disclosure Drug Development US Investors BioNxt Solutions OTCQB Market

Accesswire

Published on 12/05/2025 at 17:15, 17 minutes ago

TRX GOLD Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 17:00, 32 minutes ago

Three Trillion-Dollar Frontiers, One Technology: How SMX Is Everywhere at Once
Published on 12/05/2025 at 16:00, 1 hour 32 minutes ago

SMX Didn't Change Its Story; The World Finally Connected the Dots
Published on 12/05/2025 at 15:45, 1 hour 47 minutes ago

Critical Elements announce la clôture d'un placement privé de 7,0 $ million ca par voie de prise ferme
Published on 12/05/2025 at 15:45, 1 hour 47 minutes ago

Critical Elements Announces Closing of C$7.0 Million Bought Deal Life Private Placement

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 17:00, 32 minutes ago

EQS-Adhoc: The NAGA Group AG adjusts guidance for financial year 2025 following continued low volatility and weaker year-end performance
Published on 12/05/2025 at 16:25, 1 hour 7 minutes ago

4YFN26 Awards: Meet the Top 20 startups building the future
Published on 12/05/2025 at 16:10, 1 hour 22 minutes ago

Reorganization of the Eckert & Ziegler Executive Board
Published on 12/05/2025 at 16:00, 1 hour 32 minutes ago

EQS-Adhoc: TIN INN Holding AG implements financing strategy
Published on 12/05/2025 at 16:00, 1 hour 32 minutes ago

EQS-Adhoc: Amundi Physical Metals plc: Release of the Half-Year Financial Report as of September 30, 2025

Les Echos

Published on 12/05/2025 at 17:18, 14 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 14 minutes ago

The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 2 hours 21 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 2 hours 21 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 3 hours 34 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE

View all LES ECHOS COMFI WIRE